Skip to main content

Advertisement

SpringerLink
Log in

Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The matrix metalloproteinases (MMPs) have been shown to play important roles in cancer progression. In this study we examined whether common genetic variants in two key MMPs are associated with phenotypic features of breast cancers and patient outcome. A single nucleotide polymorphism in the promoter region of MMP-2 (−1306 C→T) abolishes Sp1 binding and is associated with lower transcriptional activity, while another in the promoter region of MMP-9 (−1562 C→T) increases the transcription of this gene. MMP-2 TT homozygous patients had smaller tumors (p=0.006) and contained lower concentrations of estrogen receptor (ER; p=0.002) compared to patients with the MMP-2 CC or CT genotype. Homozygosity for the MMP-2 −1306 T allele was associated with markedly different patient survival depending upon tumor ER status. For patients with ER negative tumors, the MMP-2 TT genotype was associated with poor survival (2/8 patients alive at end of study, 25%) compared to the CC or CT genotypes (59/70, 84%; p < 0.001). For patients with ER positive tumors, the MMP-2 TT genotype was associated with a trend for very good survival (10/10, 100%) compared to the CC or CT genotypes (130/157, 83%; p=0.16). The MMP-9 −1562 T allele was associated with features of good prognosis including non-ductal type histology, positive ER status and the absence of TP53 mutation. Patients with MMP-9 −1562 CT or TT genotypes showed marginally better prognosis compared to CC homozygotes (p=0.06). These findings suggest that breast cancer phenotype and outcome can be influenced by common functional polymorphisms in MMP genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ER:

estrogen receptor

MMP:

matrix metalloproteinase

References

  • S Curran GI Murray (2000) ArticleTitleMatrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis Eur J Cancer 36 1621–1630

    Google Scholar 

  • J Westermarck VM Kahari (1999) ArticleTitleRegulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 781–792

    Google Scholar 

  • A Talvensaari-Mattila P Paakko T Turpeenniemi-Hujanen (1999) ArticleTitleMMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma Breast Cancer Res Treat 58 287–293

    Google Scholar 

  • A Talvensaari-Mattila P Paakko G Blanco-Sequeiros T Turpeenniemi-Hujanen (2001) ArticleTitleMatrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy Breast Cancer Res Treat 65 55–61

    Google Scholar 

  • A Talvensaari-Mattila P Paakko T Turpeenniemi-Hujanen (2003) ArticleTitleMatrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma Br J Cancer 89 1270–1275

    Google Scholar 

  • R Hirvonen A Talvensaari-Mattila P Paakko T Turpeenniemi-Hujanen (2003) ArticleTitleMatrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma Breast Cancer Res Treat 77 85–91

    Google Scholar 

  • EA Garbett MW Reed NJ Brown (1999) ArticleTitleProteolysis in human breast and colorectal cancer Br J Cancer 81 287–293

    Google Scholar 

  • H Iwata S Kobayashi H Iwase A Masaoka N Fujimoto Y Okada (1996) ArticleTitleProduction of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas Jpn J Cancer Res 87 602–611

    Google Scholar 

  • MM Pacheco M Mourao EB Mantovani IN Nishimoto MM Brentani (1998) ArticleTitleExpression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations Clin Exp Metastasis 16 577–585

    Google Scholar 

  • KS Lee SY Rha SJ Kim JH Kim JK Roh BS Kim HC Chung (1996) ArticleTitleSequential activation and production of matrix metalloproteinase-2 during breast cancer progression Clin Exp Metastasis 14 512–519

    Google Scholar 

  • L Nakopoulou I Tsirmpa P Alexandrou A Louvrou C Ampela S Markaki PS Davaris (2003) ArticleTitleMMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival Breast Cancer Res Treat 77 145–155

    Google Scholar 

  • O Brummer S Athar L Riethdorf T Loning H Herbst (1999) ArticleTitleMatrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study Virchows Arch 435 566–573

    Google Scholar 

  • JL Jones P Glynn RA Walker (1999) ArticleTitleExpression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas J Pathol 189 161–168

    Google Scholar 

  • V Djonov N Cresto DM Aebersold PH Burri HJ Altermatt M Hristic G Berclaz A Ziemiecki AC Andres (2000) ArticleTitleTumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer Int J Oncol 21 25–30

    Google Scholar 

  • M Polette N Gilbert I Stas B Nawrocki A Noel A Remacle WG Stetler-Stevenson P Birembaut M Foidart (1994) ArticleTitleGelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy Virchows Arch 424 641–645

    Google Scholar 

  • SY Rha WI Yang JH Kim JK Roh JS Min KS Lee BS Kim HC Chung (1998) ArticleTitleDifferent expression patterns of MMP-2 and MMP-9 in breast cancer Oncol Rep 5 875–879

    Google Scholar 

  • SY Rha JH Kim JK Roh KS Lee JS Min BS Kim HC Chung (1997) ArticleTitleSequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression Breast Cancer Res Treat 43 175–181

    Google Scholar 

  • S Leppa T Saarto L Vehmanen C Blomqvist I Elomaa (2004) ArticleTitleA high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma Clin Cancer Res 10 1057–1063

    Google Scholar 

  • SM Ranuncolo E Armanasco C Cresta E Bal De Kier Joffe L Puricelli (2003) ArticleTitlePlasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients Int J Cancer 106 745–751

    Google Scholar 

  • GL La Rocca I Pucci-Minafra A Marrazzo P Taormina S Minafra (2004) ArticleTitleZymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera Br J Cancer 90 1414–1421

    Google Scholar 

  • SJ Price DR Greaves H Watkins (2001) ArticleTitleIdentification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation J Biol Chem 276 7549–7558

    Google Scholar 

  • Y Zhou C Yu X Miao W Tan G Liang P Xiong T Sun D Lin (2004) ArticleTitleSubstantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes Carcinogenesis 25 399–404

    Google Scholar 

  • C Yu K Pan D Xing G Liang W Tan L Zhang D Lin (2002) ArticleTitleCorrelation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer Cancer Res 62 6430–6433

    Google Scholar 

  • X Miao C Yu W Tan P Xiong G Liang W Lu D Lin (2003) ArticleTitleA functional polymorphism in the matrix metalloproteinase-2 gene promoter (–1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma Cancer Res 63 3987–3990

    Google Scholar 

  • B Zhang S Ye SM Herrmann P Eriksson M de Maat A Evans D Arveiler G Luc F Cambien A Hamsten H Watkins AM Henney (1999) ArticleTitleFunctional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis Circulation 99 1788–1794

    Google Scholar 

  • GT Jones VL Phillips EL Phillips JI Rossaak AM Rossaak (2003) ArticleTitleFunctional matrix metalloproteinase-9 polymorphism (C–1562T) associated with abdominal aortic aneurysm J Vasc Surg 38 1363–1367

    Google Scholar 

  • BL Powell IL van Staveren P Roosken F Grieu EM Grieu B Iacopetta (2002) ArticleTitleAssociations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer Carcinogenesis 23 311–315

    Google Scholar 

  • BL Powell D Piersma ME Kevenaar IL van Staveren AP Themmen BJ Themmen EM Themmen (2003) ArticleTitleLuteinizing hormone signaling and breast cancer: polymorphisms and age of onset J Clin Endocrinol Metab 88 1653–1657

    Google Scholar 

  • B Iacopetta F Grieu D Joseph (2004) ArticleTitleThe -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype Br J Cancer 90 419–422

    Google Scholar 

  • R Soong BJ Iacopetta JM Harvey GF Sterrett HJ Dawkins R Hahnel PD Robbins (1997) ArticleTitleDetection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer Int J Cancer 74 642–647

    Google Scholar 

  • F Grieu D Joseph P Norman B Iacopetta (2004) ArticleTitleDevelopment of a rapid genotyping method for single nucleotide polymorphisms and its application in cancer studies Oncol Rep 11 501–504

    Google Scholar 

  • N Lamblin C Bauters X Hermant JM Lablanche N Helbecque P Amouyel (2002) ArticleTitlePolymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease J Am Coll Cardiol 40 43–48

    Google Scholar 

  • G Giannelli A Pozzi WG Stetler-Stevenson HA Gardner V Quaranta (1999) ArticleTitleExpression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids Am J Pathol 154 1193–1201

    Google Scholar 

  • S Harendza DH Lovett U Panzer Z Lukacs P Kuhnl RA Stahl (2003) ArticleTitleLinked common polymorphisms in the gelatinase A promoter are associated with diminished transcriptional response to estrogen and genetic fitness J Biol Chem 278 20490–20499

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands

    Fabienne Grieu

  2. School of Surgery and Pathology, University of Western Australia, 35 Stirling Hwy, Crawley, 6009, Australia

    Wei Qi Li & Barry Iacopetta

Authors
  1. Fabienne Grieu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Qi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barry Iacopetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barry Iacopetta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grieu, F., Li, W.Q. & Iacopetta, B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88, 197–204 (2004). https://doi.org/10.1007/s10549-004-0595-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-004-0595-6

Keywords

Search

Navigation